The long-term outcome in patients with superficial transitional cell carcinoma of the bladder: A single-institutional experience

BJU International

Volumn 83, Issue 9, 1999, Pages 957-963

  Haukaas, S ^a   DAEhlin L ^a   Maartmann Moe, H ^b   Ulvik, N M ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bladder neoplasms; Carcinoma; Prognosis; Transitional cell

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CAUSE OF DEATH; CYSTECTOMY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NORWAY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 0033016139     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00078.x     Document Type: Article

References (21)

1. 1 Smith JA Jr. Surgical management of superficial bladder cancer (stages Ta/T1/CIS). Semin Surg Oncol 1997; 13: 328-34
2. 2 Holmäng S, Hedelin H, Anderström C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995; 153: 1823-7
3. 3 Malmström PU, Busch C, Norlén BJ. Recurrence, progression and survival in bladder cancer: a retrospective analysis of 232 patient with ≥ 5-year follow-up. Scand J Urol Nephrol 1987; 21: 185-95
4. 4 Jakse G, Loidl W, Seeber G, Hofstädter F. Stage T1 grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol 1987; 137: 39-43
5. 5 Torti FM, Lum BL, Aston D et al. Superficial bladder cancer: The primacy of grade in the development of invasive disease. J Clin Oncol 1987; 5: 125-30
6. 6 Lapham RL, Ro JY, Staerkel GA, Ayala AG. Pathology of transitional cell carcinoma of the bladder and its clinical implications. Semin Surg Oncol 1997; 13: 307-18
7. 7 Hermann GG, Horn T, Steven K. The influence of level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer. J Urol 1998; 159: 91-4
8. 8 Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997; 157: 800-3
9. 9 Farsund T, Høstmark JG, Lœrum OD. Relation between flow cytometric DNA distribution and pathology in human bladder cancer. Cancer 1984; 54: 1771-7
10. 10 Esrig D, Elmajian D, Groshen S et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994; 331: 1259-64
11. 11 Kurth K, Tunn U, Ay R et al. Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of an European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone. J Urol 1997; 158: 378-84
12. 12 Cookson MS, Herr HW, Zhang Z-F, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997; 158: 62-7
13. 13 Harmer MH. TNM Classification of Malignant Tumors 3rd edn. Geneva: International Union Against Cancer 1978
14. 14 Mostofi FK, Sorbin LH, Torloni H. Histological Typing of Urinary Bladder Tumors. International Classification of Tumors No 10. Geneva: WHO 1973
15. 15 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Stat Ass 1958; 53: 457-81
16. 16 Breslow NE, Day NE. Statistical Methods in Cancer Research. II. The Design and Analysis of Cohort Studies. Lyon: IARC 1987
17. 17 Utz DC, Farrow GM. Carcinoma in situ of the urinary tract. Urol Clin North Am 1984; 11: 735-40
18. 18 Heney NM, Ahmed S, Flanagan MJ et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 1083
19. 19 Prout GR Jr, Barton BA, Griffin PP, Friedell GH. Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol 1992; 148: 1413-9
20. 20 Vatne V, Høstmark J, Litlekalsøy J, Fjellbirkeland L. A human in vitro model of bladder tumor cell invasion. Anticancer Res 1998; 18: 3985-9
21. 21 Pham HT, Soloway MS. High-risk superficial bladder cancer: intravesical therapy for T1, G3 transitional cell carcinoma of the urinary bladder. Semin Urol Oncol 1997; 15: 147-53